about
Cellular traction stresses increase with increasing metastatic potentialComputational genes: a tool for molecular diagnosis and therapy of aberrant mutational phenotypeChip-NMR biosensor for detection and molecular analysis of cellsTransforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variationsGenetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumorsGenomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical PracticeMolecular biomarkers for the detection of metastatic colorectal cancer cellsPerspectives on new biomarkers in gastric cancer: diagnostic and prognostic applicationsNUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patientsBiomarkers in cancer staging, prognosis and treatment selectionCirculating mutant DNA to assess tumor dynamicsNovel quantitative real-time LCR for the sensitive detection of SNP frequencies in pooled DNA: method development, evaluation and applicationUtilizing the molecular gateway: the path to personalized cancer management.Protein thiols and butryrylcholinestrase in saliva of oral cancer patients.Nanobiosensors: optofluidic, electrical and mechanical approaches to biomolecular detection at the nanoscale.Gene expression profiling using laser capture microdissection.IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor markerGenetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.Assessing the clinical utility of genomic expression data across human cancers.miR-365 promotes cutaneous squamous cell carcinoma (CSCC) through targeting nuclear factor I/B (NFIB)Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer.Differential exoprotease activities confer tumor-specific serum peptidome patternsA minimally invasive multiple marker approach allows highly efficient detection of meningioma tumorsAutomated serum peptide profiling.DNA degradation test predicts success in whole-genome amplification from diverse clinical samples.A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery.DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection.Performance of mitochondrial DNA mutations detecting early stage cancer.Mutation detection by real-time PCR: a simple, robust and highly selective method.Microarray-based multiplexed scanometric immunoassay for protein cancer markers using gold nanoparticle probesCapillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profilesDiscovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.Sensitive digital quantification of DNA methylation in clinical samples.Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patientsEstrogen receptor-alpha methylation predicts melanoma progressionHigh-Density Genetic Linkage Map Construction and Quantitative Trait Locus Mapping for Hawthorn (Crataegus pinnatifida Bunge).Single-wall carbon nanotube forest arrays for immunoelectrochemical measurement of four protein biomarkers for prostate cancer.
P2860
Q21134747-AE3CE01D-EC66-4054-9878-D42A8E7AAEEBQ21284221-E84BCDE0-4CD9-477B-AB25-AE905814FA49Q24649550-798EFED2-BBC5-4128-A52A-B12D6519F376Q24678861-A80F2F10-B361-4033-B279-6A17020BAF92Q26738567-AB5FED29-5F67-41E5-90CC-658310274E6DQ26740622-9B8E1BBB-D4D6-4B41-B56E-042A870B16A1Q27002450-2A47400A-044E-4553-B629-8E17DFD73817Q27012898-63F997C8-9D81-46F2-A366-279295EF3C53Q27348507-B719A4FE-464C-4E12-B1A7-3F90EDE0F263Q28264105-296E72D8-FBDC-43BD-B1E9-59E91C6EE02DQ28278305-CA6321BF-727F-43AA-ADFB-A03DD8561B56Q28289337-BEDF8C4D-5610-4CA9-A5E8-CCF89541869CQ28476768-A99F20FC-79F4-4F1A-B8A2-810276471764Q30371443-94C38140-90B3-43F0-A204-8734DA5A1E7AQ30415247-F21F98DE-46DE-44C8-9797-9427A231F5DCQ30493312-19067F44-BA4E-4A52-8094-1E2C1BEE81B7Q30852806-9A910120-977A-4EDE-B579-7E103B159E1BQ31002231-755E5EEA-6F3B-45A9-B6FF-5700793E24BBQ31031951-AB78D81D-BCD9-4250-B02A-1DF1C3806DFBQ31037974-918CDA85-2F5D-44AC-864C-2EC4878A0944Q31109151-523226FE-4F8B-4E50-B84D-624B7F9D0C32Q31166675-CDBFD1F0-78A9-4E36-934C-B5120247F542Q33214731-A4AC84CC-FD9A-49A8-9F91-4EFB72C0981CQ33230965-5CF56D4D-7C50-4369-9FBC-1678EC5E59DBQ33267383-CA37B494-1662-474B-91BD-A867DB5BDEB9Q33280949-922446A8-FE9B-44F6-B68D-4D97AFCA0E08Q33293788-8E2803C5-1ACD-4581-B321-47173CA35A47Q33305170-1E4BB7D0-5D7B-4B11-B283-D256ABE66C54Q33360111-41C446B8-B18F-4206-8014-E8FB9F1BFA51Q33373844-49EF1EF9-95C6-49A8-A17E-B243C7AF0106Q33412122-DEC387B7-FA16-49AA-A91B-E4B89508449CQ33513706-68C12E8D-C8AF-43AA-86AD-44AFD28DC7D6Q33639706-A0BA07E7-83E9-4514-847C-C1C2C0468987Q33647672-CE86C979-7E0F-472A-A430-BE005293C93CQ33761814-6C93B685-B9E0-49C1-B99E-3C792D889E94Q33796956-D02D2368-3626-4AFE-9229-4049E8BA5F9CQ33797039-061ECB08-BB21-452C-86E4-CF52E9F407F1Q33797076-26FC35F6-E479-4083-9480-224FB725C1ECQ33905748-3F34B5C0-F9C2-4AC2-B2E0-904A1CE0902DQ33982421-27A7D2A8-4506-4795-87C6-AB53E68F2052
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Emerging molecular markers of cancer.
@ast
Emerging molecular markers of cancer.
@en
type
label
Emerging molecular markers of cancer.
@ast
Emerging molecular markers of cancer.
@en
prefLabel
Emerging molecular markers of cancer.
@ast
Emerging molecular markers of cancer.
@en
P2860
P356
P1476
Emerging molecular markers of cancer.
@en
P2093
David Sidransky
P2860
P2888
P304
P356
10.1038/NRC755
P407
P577
2002-03-01T00:00:00Z
P5875
P6179
1049934401